Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade
- 14 September 2003
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 9 (10) , 1275-1280
- https://doi.org/10.1038/nm931
Abstract
Although the underlying mechanisms are not well understood, it is generally believed that antigen recognition by T cells in the absence of costimulation may alter the immune response, leading to anergy or tolerance. Further support for this concept comes from animal models of autoimmunity and transplantation, where treatments based on costimulation blockade, in particular CD40 ligand (CD40L)-specific antibodies, have been highly effective. We investigated the mechanisms of action of an antibody to CD40L and provide evidence that its effects are dependent on the constant (Fc) region. Prolongation of graft survival is dependent on both complement- and Fc receptor–mediated mechanisms in a major histocompatibility complex (MHC)-mismatched skin transplant model. These data suggest that antibodies to CD40L act through selective depletion of activated T cells, rather than exerting immune modulation by costimulation blockade as currently postulated. This finding opens new avenues for treatment of immune disorders based on selective targeting of activated T cells.Keywords
This publication has 43 references indexed in Scilit:
- Transplantation tolerance—where do we stand?Nature Medicine, 1999
- Graft tolerance: A duel of two signalsNature Medicine, 1999
- Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primatesNature Medicine, 1999
- T Cell Costimulatory BlockadeJournal of the American Society of Nephrology, 1999
- Current trends in transplant immunologyCurrent Opinion in Nephrology and Hypertension, 1999
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- The Role of CD40 Ligand in Costimulation and T‐Cell ActivationImmunological Reviews, 1996
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- T‐Cell Unresponsiveness in vivo and in vitro: Fine Specificity of Induction and Molecular Characterization of the Unresponsive StateImmunological Reviews, 1987